(S)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one
CAS : 104266-90-2
Ref. 3D-EEA26690
1g | Arrêté | ||
5g | Arrêté | ||
10g | Arrêté | ||
25g | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- (4S)-3-(3-Methyl-1-oxobutyl)-4-(phenylmethyl)-2-oxazolidinone
- (4S)-4-Benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one
- (4S)-4-Benzyl-3-isovaleryloxazolidin-2-one
- (S)-3-(3-Methylbutanoyl)-4-benzyloxazolidin-2-one
- 2-Oxazolidinone, 3-(3-methyl-1-oxobutyl)-4-(phenylmethyl)-, (4S)-
- 2-Oxazolidinone, 3-(3-methyl-1-oxobutyl)-4-(phenylmethyl)-, (S)-
- 3-Isovaleroyl-4-(S)-Benzyloxazolidin-2-One
- 3-isovaleroyl-4-(S)-benzyl-oxazolidin-2-one
(S)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one is an enantiomerically pure chiral compound. It is a Friedel-Crafts alkylation of 2,6-dichloroquinoline with 3-methylbutanal. This intermediate was used to synthesize the antihypertensive drug aliskiren. (S)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one is a chiral reductively activated intermediate that can be used in the preparation of other chiral compounds.